
Arthroplasty
Evaluation of the need for blood transfusion with the use of a bipolar sealer
J Bone Joint Surg Am. 2011 Mar 16;93(6):513-8140 patients undergoing primary total hip arthroplasty were randomized into two different groups receiving differing blood management procedures. The treatment group received radiofrequency energy using an aquamantys 6.0 bipolar sealer, and the control group received standard Bovie electrocautery. The results from this trial indicated no significant differences between the two groups in terms of number blood transfusions and total blood loss, suggeting that the bipolar sealer did not improve hemostasis during total hip arthroplasty.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.